A New Lipidomics Software Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

Postery | 2019 | Agilent TechnologiesInstrumentace
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Zaměření
Klinická analýza, Lipidomika
Výrobce
Agilent Technologies
Přejít do knihovnyZobrazit PDF
PDF verze ke stažení a čtení
 

Podobná PDF

Metabolomics: An Improved Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
Metabolomics: An Improved Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
2019|Agilent Technologies|Postery
Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
2020|Agilent Technologies|Aplikace
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with Untargeted Metabolomics
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with Untargeted Metabolomics
2023|Agilent Technologies|Postery
Automated Dual Metabolite+Lipid Cell Sample Prep as a Component of an LC/HRMS-based Workflow to Elucidate the Molecular Response to Drug Treatment
Automated Dual Metabolite+Lipid Cell Sample Prep as a Component of an LC/HRMS-based Workflow to Elucidate the Molecular Response to Drug Treatment
2021|Agilent Technologies|Postery